University of Thessaly (UTH)
Συστηματική φλεγμονή και παράμετροι καρδιαγγειακού κινδύνου σε ασθενείς με χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
Abstract
dc:descriptionCOPD is characterized by extrapulmonary manifestations, including anemia, cachexia, osteoporosis and increased risk for the development of cardiovascular disease, diabetes mellitus and metabolic syndrome.In an attempt to optimize the evaluation of COPD patients and their treatment, an overall approach of the disease is required. Moreover, it is necessary to identify the different phenotypes of COPD. For this reason, several biomarkers have been evaluated.Fetuin-A is a glycoprotein derived from liver parenchymal cells resulting from the release of proinflammatory cytokines. Fetuin-A promotes insulin resistance, inhibits vascular and bone calcification and enhances phagocytosis. In the present study we assessed the levels of Fetuin-A in COPD patients on stable condition and on exacerbation, in an attempt to evaluate it as a clinically relevant biomarker that may serve as predictor of exacerbations of COPD.One hundred COPD outpatients (GOLD stage I-IV) were enrolled in a tertiary University hospital and forty healthy smokers served as controls. All the participants were submitted to a detailed evaluation, including pulmonary function testing, exercise capacity and quality of life. Blood samples were obtained for the evaluation of Fetuin-A, CRP and parameters of metabolic syndrome. All patients were followed-up for 1 year and 36 of them were re-evaluated at the onset of a COPD exacerbation.Serum Fetuin-A levels were reproducible at baseline, 6 and 12 months. COPD patients presented lower levels of Fetuin-A compared to controls [394.5 (321.8-419.6)mg/L vs. 487.3 (441.0-548.0)mg/L, p<0.001]. COPD patients with GOLD stage IV had lower Fetuin-A levels compared to stages I-II and III (p<0.05). Fetuin-A was significantly reduced at the onset of an exacerbation compared to baseline (p<0.001) and the time to the first exacerbation was significantly different between patients with high and low levels of Fetuin-A [HR 2.163 (95% CI 1.104-4.238), p=0.024].The results of the present study suggest that Fetuin-A is a reproducible and clinically relevant biomarker in patients with COPD that may be useful in the identification of exacerbation-prone patients.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mystridou, Parthena
- Μυστρίδου, Παρθένα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35041